Pancreatic involvement in small cell lung cancer
- PMID: 24587774
- PMCID: PMC3908842
- DOI: 10.2478/raon-2013-0022
Pancreatic involvement in small cell lung cancer
Abstract
Background: Few data are available concerning incidence, clinical picture, and prognosis for pancreatic metastases of small cell lung carcinoma. In this paper we review the related literature available in English language.
Conclusions: Although pancreatic metastases are generally asymptomatic, they can rarely produce clinical symptoms or functional abnormalities. The widespread use of multi-detector computerised tomography (CT) in contemporary medical practice has led to an increased detection of pancreatic metastases in oncology patients. Tissue diagnosis is imperative because radiological techniques alone are incapable of differentiating them from primary pancreatic tumours. Pancreatic metastases occur in the relative end stage of small cell lung cancer. The main complications of these lesions, although rare, are acute pancreatitis and obstructive jaundice. Early chemotherapy can provide a survival benefit even in patients with mild acute pancreatitis or extrahepatic biliary obstruction.
Keywords: carcinoma; lung neoplasms; neoplasm metastasis; pancreas; small cell.
References
-
- Sakamoto H, Kitano M, Komaki T, Noda K, Chikugo T, Kudo M. Small cell carcinoma of the pancreas: role of EUS-FNA and subsequent effective chemotherapy using carboplatin and etoposide. J Gastroenterol. 2009;44:432–8. - PubMed
-
- Iwasa S, Morizane C, Okusaka T, Ueno H, Ikeda M, Kondo S, et al. Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas. Jpn J Clin Oncol. 2010;40:313–8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
